Cat
Name
Size
Price
Action
MBS618480-01
Adipose Triglyceride Lipase (ATGL, Desnutrin, Phospholipase A2 zeta)
1 Each
Ask
MBS618480-02
Adipose Triglyceride Lipase (ATGL, Desnutrin, Phospholipase A2 zeta)
5x 1 Each
Ask
MBS611367-01
Adipose Triglyceride Lipase (ATGL, Desnutrin, Phospholipase A2 zeta)
0.1 mL
Ask
MBS611367-02
Adipose Triglyceride Lipase (ATGL, Desnutrin, Phospholipase A2 zeta)
5x 0.1 mL
Ask
MBS610316-01
Adipose Triglyceride Lipase (ATGL, Desnutrin, Phospholipase A2 zeta)
0.1 mL
Ask
MBS610316-02
Adipose Triglyceride Lipase (ATGL, Desnutrin, Phospholipase A2 zeta)
5x 0.1 mL
Ask
MBS645591-01
PLA2G16 (Group XVI Phospholipase A2, Adipose-specific Phospholipase A2, AdPLA, H-rev 107 Protein Homolog, HRAS-like Suppressor 3, HREV107, HREV107-3, Renal Carcinoma Antigen NY-REN-65, HRASLS3)
0.1 mg
Ask
MBS645591-02
PLA2G16 (Group XVI Phospholipase A2, Adipose-specific Phospholipase A2, AdPLA, H-rev 107 Protein Homolog, HRAS-like Suppressor 3, HREV107, HREV107-3, Renal Carcinoma Antigen NY-REN-65, HRASLS3)
5x 0.1 mg
Ask
MBS630473-01
PLA2G16 (Group XVI Phospholipase A2, Adipose-specific Phospholipase A2, AdPLA, H-rev 107 Protein Homolog, HRAS-like Suppressor 3, HREV107, HREV107-3, Renal Carcinoma Antigen NY-REN-65, HRASLS3)
0.1 mg
Ask
MBS630473-02
PLA2G16 (Group XVI Phospholipase A2, Adipose-specific Phospholipase A2, AdPLA, H-rev 107 Protein Homolog, HRAS-like Suppressor 3, HREV107, HREV107-3, Renal Carcinoma Antigen NY-REN-65, HRASLS3)
5x 0.1 mg
Ask
MBS6011519-01
PLA2G16, NT (Group XVI Phospholipase A2, Adipose-specific Phospholipase A2, AdPLA, H-rev 107 Protein Homolog, HRAS-like Suppressor 3, HREV107, HREV107-3, Renal Carcinoma Antigen NY-REN-65, HRASLS3)
0.05 mg
Ask
MBS6011519-02
PLA2G16, NT (Group XVI Phospholipase A2, Adipose-specific Phospholipase A2, AdPLA, H-rev 107 Protein Homolog, HRAS-like Suppressor 3, HREV107, HREV107-3, Renal Carcinoma Antigen NY-REN-65, HRASLS3)
5x 0.05 mg
Ask
MBS644621-01
PLA2G16 (Group XVI Phospholipase A2, Adipose-specific Phospholipase A2, AdPLA, H-rev 107 Protein Homolog, HRAS-like Suppressor 3, HREV107, HREV107-3, Renal Carcinoma Antigen NY-REN-65, HRASLS3, MGC118754)
0.1 mL
Ask
MBS644621-02
PLA2G16 (Group XVI Phospholipase A2, Adipose-specific Phospholipase A2, AdPLA, H-rev 107 Protein Homolog, HRAS-like Suppressor 3, HREV107, HREV107-3, Renal Carcinoma Antigen NY-REN-65, HRASLS3, MGC118754)
5x 0.1 mL
Ask
MBS6381650-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (AP)
0.1 mL
Ask
MBS6381650-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (AP)
5x 0.1 mL
Ask
MBS6381651-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) APC
0.1 mL
Ask
MBS6381651-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) APC
5x 0.1 mL
Ask
MBS6381660-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (PE)
0.1 mL
Ask
MBS6381660-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (PE)
5x 0.1 mL
Ask
MBS6158262-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (PE)
0.1 mL
Ask
MBS6158262-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (PE)
5x 0.1 mL
Ask
MBS6147656-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (FITC)
0.1 mL
Ask
MBS6147656-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (FITC)
5x 0.1 mL
Ask
MBS6308332-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (APC)
0.2 mL
Ask
MBS6308332-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (APC)
5x 0.2 mL
Ask
MBS6308339-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (MaxLight 650)
0.1 mL
Ask
MBS6308339-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (MaxLight 650)
5x 0.1 mL
Ask
MBS6003669-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754)
0.05 mg
Ask
MBS6003669-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754)
5x 0.05 mg
Ask
MBS6308333-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (Biotin)
0.2 mL
Ask
MBS6308333-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (Biotin)
5x 0.2 mL
Ask
MBS6308334-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (FITC)
0.2 mL
Ask
MBS6308334-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (FITC)
5x 0.2 mL
Ask
MBS6308335-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (HRP)
0.2 mL
Ask
MBS6308335-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (HRP)
5x 0.2 mL
Ask
MBS6308338-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (MaxLight 550)
0.1 mL
Ask
MBS6308338-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (MaxLight 550)
5x 0.1 mL
Ask
MBS6308341-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (PE)
0.2 mL
Ask
MBS6308341-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (PE)
5x 0.2 mL
Ask
MBS6137050-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) APC
0.1 mL
Ask
MBS6137050-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) APC
5x 0.1 mL
Ask
MBS6381654-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (HRP)
0.1 mL
Ask
MBS6381654-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (HRP)
5x 0.1 mL
Ask
MBS6001811-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754)
0.1 mg
Ask
MBS6001811-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754)
5x 0.1 mg
Ask
MBS6152959-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (HRP)
0.1 mL
Ask
MBS6152959-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (HRP)
5x 0.1 mL
Ask
MBS6308331-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (AP)
0.2 mL
Ask
MBS6308331-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (AP)
5x 0.2 mL
Ask
MBS6308336-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (MaxLight 405)
0.1 mL
Ask
MBS6308336-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (MaxLight 405)
5x 0.1 mL
Ask
MBS6308337-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (MaxLight 490)
0.1 mL
Ask
MBS6308337-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (MaxLight 490)
5x 0.1 mL
Ask
MBS6308340-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (MaxLight 750)
0.1 mL
Ask
MBS6308340-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (MaxLight 750)
5x 0.1 mL
Ask
MBS6131747-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (AP)
0.1 mL
Ask
MBS6131747-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (AP)
5x 0.1 mL
Ask
MBS6381653-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (FITC)
0.1 mL
Ask
MBS6381653-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (FITC)
5x 0.1 mL
Ask
MBS6009757-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65)
0.2 mL
Ask
MBS6009757-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65)
5x 0.2 mL
Ask
MBS6002843-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754)
0.1 mg
Ask
MBS6002843-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754)
5x 0.1 mg
Ask
MBS6381655-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
0.1 mL
Ask
MBS6381655-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
5x 0.1 mL
Ask
MBS6381656-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
0.1 mL
Ask
MBS6381656-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
5x 0.1 mL
Ask
MBS6211960-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
0.1 mL
Ask
MBS6211960-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
5x 0.1 mL
Ask
MBS6142353-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (Biotin)
0.1 mL
Ask
MBS6142353-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (Biotin)
5x 0.1 mL
Ask
MBS6381657-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
0.1 mL
Ask
MBS6381657-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
5x 0.1 mL
Ask
MBS6381658-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
0.1 mL
Ask
MBS6381658-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
5x 0.1 mL
Ask
MBS6190610-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
0.1 mL
Ask
MBS6190610-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
5x 0.1 mL
Ask
MBS6381652-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (Biotin)
0.1 mL
Ask
MBS6381652-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (Biotin)
5x 0.1 mL
Ask
MBS6381659-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
0.1 mL
Ask
MBS6381659-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
5x 0.1 mL
Ask
MBS6233310-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
0.1 mL
Ask
MBS6233310-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
5x 0.1 mL
Ask
MBS6222635-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
0.1 mL
Ask
MBS6222635-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
5x 0.1 mL
Ask
MBS6201285-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
0.1 mL
Ask
MBS6201285-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
5x 0.1 mL
Ask
YF-MA19023
Anti-Adipose Triglyceride Lipase (2H1)
100 ug
Ask
20-105
Adipose Subcutaneous Diabetic Disease Lysate
0.1 mg
Ask
C1236003SubDia-10
cDNA - Human Diabetic Diseased Tissue: Subcutaneous Adipose
10 RXN
Ask
OCPB00186-100UG
OCPB00186-100UG - Adipose Subcutaneous Diabetic Disease Lysate
0.1 mg
Ask
MBS640907-01
Tissue, Section, Human Disease, Diabetes, Subcutaneous Adipose (Frozen)
5 Slides
Ask
MBS640907-02
Tissue, Section, Human Disease, Diabetes, Subcutaneous Adipose (Frozen)
5x 5 Slides
Ask
P1236003SubDia
Total-Protein---Human-Diabetic-Diseased-Tissue:-Subcutaneous-Adipose
1 mg
Ask
MBS657155-01
Tissue, Total Protein, Human Disease, Diabetes, Subcutaneous Adipose
1 mg
Ask
MBS657155-02
Tissue, Total Protein, Human Disease, Diabetes, Subcutaneous Adipose
5x 1 mg
Ask
T1236003SubDia
Frozen-Tissue-Section---Human-Diabetic-Diseased-Tissue:-Subcutaneous-Adipose
5 Slides
Ask
D1236003SubDia
Genomic DNA - Human Diabetic Diseased Tissue: Subcutaneous Adipose, from a single donor
50 µg
Ask
MBS173266-01
Human Adipose Tissue - Subcutaneous Fat Cells
1 g
Ask
MBS173266-02
Human Adipose Tissue - Subcutaneous Fat Cells
5x 1 g
Ask
BS46562
Adipose Triglyceride Lipase Recombinant Rabbit mAb
50 ul
Ask
BS45600
Adipose Triglyceride Lipase Recombinant Rabbit mAb
50 ul
Ask
E45H39228M5
Adipose Triglyceride Lipase (PNPLA2) (NM_020376) Human Recombinant Protein
20 ug
Ask
RPA706Ra01-10ug
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
10 µg
Ask
MBS2010135-01
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
0.01 mg
Ask
MBS2010135-02
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
0.05 mg
Ask
MBS2010135-03
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
0.1 mg
Ask
MBS2010135-04
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
0.2 mg
Ask
MBS2010135-05
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
0.5 mg
Ask
MBS2010135-06
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
1 mg
Ask
MBS2010135-07
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
2 mg
Ask
MBS2010135-08
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
5 mg
Ask
MBS2010135-09
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
5x 5 mg
Ask
RPU44350-01
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
50 µg
Ask
RPU44350-02
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
100 µg
Ask
RPU44350-03
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
1 mg
Ask
RPU44351-01
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
50 µg
Ask
RPU44351-02
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
100 µg
Ask
RPU44351-03
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
1 mg
Ask
MBS2009446-01
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
0.01 mg
Ask
MBS2009446-02
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
0.05 mg
Ask
MBS2009446-03
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
0.1 mg
Ask
MBS2009446-04
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
0.2 mg
Ask
MBS2009446-05
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
0.5 mg
Ask
MBS2009446-06
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
1 mg
Ask
MBS2009446-07
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
2 mg
Ask
MBS2009446-08
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
5 mg
Ask
MBS2009446-09
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
5x 5 mg
Ask
SIPA859Mu01-01
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
10 µg
Ask
SIPA859Mu01-02
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
50 µg
Ask
SIPA859Mu01-03
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
200 µg
Ask
SIPA859Mu01-04
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
1 mg
Ask
SIPA859Mu01-05
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
5 mg
Ask
RPA706Hu01-10ug
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
10 µg
Ask
RPA706Ra01-50ug
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
50 µg
Ask
T0542
Immortalized Mouse Subcutaneous Adipose Multipotent Mesenchymal Cells (m17.ASC)
1x106 cells / 1.0 ml
Ask
HA721951
Adipose Triglyceride Lipase Recombinant Rabbit Monoclonal Antibody [JE37-49]
100 µL
Ask
RPA706Hu01-01
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
10 µg
Ask
RPA706Hu01-02
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
50 µg
Ask
RPA706Hu01-03
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
100 µg
Ask
RPA706Hu01-04
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
200 µg
Ask
RPA706Hu01-05
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
500 µg
Ask
RPA706Hu01-06
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
1 mg
Ask
RPA706Mu01-10ug
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
10 µg
Ask
SIPA859Mu02-01
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
10 µg
Ask
SIPA859Mu02-02
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
50 µg
Ask
SIPA859Mu02-03
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
200 µg
Ask
SIPA859Mu02-04
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
1 mg
Ask
SIPA859Mu02-05
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
5 mg
Ask
SIPA859Ra01-01
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
10 µg
Ask
SIPA859Ra01-02
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
50 µg
Ask
SIPA859Ra01-03
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
200 µg
Ask
SIPA859Ra01-04
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
1 mg
Ask
SIPA859Ra01-05
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
5 mg
Ask
RPU56800-01
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
50 µg
Ask
RPU56800-02
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
100 µg
Ask
RPU56800-03
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
1 mg
Ask
RPU44352-01
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
50 µg
Ask
RPU44352-02
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
100 µg
Ask
RPU44352-03
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
1 mg
Ask
RPA706Mu01-01
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
10 µg
Ask
RPA706Mu01-02
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
50 µg
Ask
RPA706Mu01-03
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
100 µg
Ask
RPA706Mu01-04
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
200 µg
Ask
RPA706Mu01-05
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
500 µg
Ask
RPA706Mu01-06
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
1 mg
Ask
T0543
Immortalized Mouse Subcutaneous Adipose Multipotent Mesenchymal Cells (m17.ASC-GFP)
1x106 cells / 1.0 ml
Ask
MBS2009503-01
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
0.01 mg
Ask
MBS2009503-02
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
0.05 mg
Ask
MBS2009503-03
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
0.1 mg
Ask
MBS2009503-04
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
0.2 mg
Ask
MBS2009503-05
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
0.5 mg
Ask
MBS2009503-06
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
1 mg
Ask
MBS2009503-07
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
2 mg
Ask
MBS2009503-08
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
5 mg
Ask
MBS2009503-09
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
5x 5 mg
Ask
RPA706Mu01-50ug
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
50 µg
Ask
RPA706Ra01-01
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
10 µg
Ask
RPA706Ra01-02
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
50 µg
Ask
RPA706Ra01-03
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
100 µg
Ask
RPA706Ra01-04
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
200 µg
Ask
RPA706Ra01-05
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
500 µg
Ask
RPA706Ra01-06
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
1 mg
Ask
RPA706Hu01-50ug
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
50 µg
Ask
SIPA859Hu01-01
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
10 µg
Ask
SIPA859Hu01-02
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
50 µg
Ask
SIPA859Hu01-03
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
200 µg
Ask
SIPA859Hu01-04
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
1 mg
Ask
SIPA859Hu01-05
Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)
5 mg
Ask
RPA706Ra01-1MG
Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin) recombinant protein
1 mg
Ask
RPA706Hu01-500ug
Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin) recombinant protein
500 µg
Ask
RPA706Hu01-200ug
Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin) recombinant protein
200 µg
Ask
RPA706Mu01-100ug
Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin) recombinant protein
100 µg
Ask
RPA706Hu01-1MG
Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin) recombinant protein
1 mg
Ask
RPA706Ra01-200ug
Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin) recombinant protein
200 µg
Ask
RPA706Mu01-1MG
Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin) recombinant protein
1 mg
Ask
RPA706Hu01-5MG
Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin) recombinant protein
5 mg
Ask
RPA706Ra01-100ug
Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin) recombinant protein
100 µg
Ask
RPA706Ra01-5MG
Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin) recombinant protein
5 mg
Ask
RPA706Ra01-500ug
Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin) recombinant protein
500 µg
Ask
RPA706Mu01-200ug
Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin) recombinant protein
200 µg
Ask
RPA706Hu01-100ug
Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin) recombinant protein
100 µg
Ask
RPA706Mu01-5MG
Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin) recombinant protein
5 mg
Ask
RPA706Mu01-500ug
Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin) recombinant protein
500 µg
Ask
MBS637567-01
Vaspin, Recombinant, Mouse (Visceral Adipose Tissue-derived Serine Protease Inhibitor, Serpin A12, OL-64)
0.01 mg
Ask
MBS637567-02
Vaspin, Recombinant, Mouse (Visceral Adipose Tissue-derived Serine Protease Inhibitor, Serpin A12, OL-64)
5x 0.01 mg
Ask
MBS635836-01
Vaspin, Recombinant, Human (Visceral Adipose Tissue-derived Serine Protease Inhibitor, Serpin A12, OL-64)
0.01 mg
Ask
MBS635836-02
Vaspin, Recombinant, Human (Visceral Adipose Tissue-derived Serine Protease Inhibitor, Serpin A12, OL-64)
5x 0.01 mg
Ask
SO242a
Multiple types liposarcoma ( DDLPS, myxoid liposarcoma, mixed-type liposarcoma, pleomorphic liposarcoma, well-differentiated liposarcoma) with adipose tissue array, including tumor grade with TNM/stage ( AJCC 8th edition), 12 cases/24 cores ( core size 2.0mm), replacing SO242-SO242a
each
Ask
YF-PA26458
anti-Adipose Triglyceride Lipase
50 ul
Ask
YF-PA20120
anti-Adipose Triglyceride Lipase
100 ug
Ask